ClinicalTrials.Veeva

Menu

Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial Lipemia

K

King's College London

Status

Completed

Conditions

Raised Fasting Plasma Triacylglycerol Concentrations
Healthy Men

Treatments

Dietary Supplement: High-fat meal containing native palm olein
Dietary Supplement: High-fat meal containing interesterified palm olein

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether high-fat meals rich in palmitic acid in the sn-2 position decrease lipaemia in men aged 40-70 y with higher than optimal fasting triacylglycerol concentrations.

Enrollment

11 patients

Sex

Male

Ages

40 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy males
  • Non-smokers
  • Aged 40-70 years
  • Fasting TAG concentrations ≥1.5 mmol/L.

Exclusion criteria

  • Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke), impaired fasting glucose/uncontrolled type 2 diabetes (or fasting glucose ≥ 6.1 mmol/L), cancer, kidney, liver or bowel disease.
  • Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption.
  • History of substance abuse or alcoholism (previous weekly alcohol intake >60 units/men)
  • Current self-reported weekly alcohol intake exceeding 28 units
  • Allergy or intolerance to any component of test meals
  • Unwilling to restrict consumption of any source of fish oil for the length of the study
  • Weight change of >3kg in preceding 2 months
  • Body Mass Index <20 and >35 kg/m2
  • Fasting blood cholesterol > 7.8 mmol/L
  • Current cigarette smoker.
  • Current use of lipid lowering medication

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

11 participants in 2 patient groups

Native palm olein
Active Comparator group
Description:
75 g native palm olein
Treatment:
Dietary Supplement: High-fat meal containing native palm olein
Interesterified palm olein
Experimental group
Description:
75 g interesterified palm olein
Treatment:
Dietary Supplement: High-fat meal containing interesterified palm olein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems